Shut Down

uBiome Stock

DNA sequencing

Sign up today and learn more about uBiome Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About uBiome Stock

uBiome is the world’s first effort to map the human microbiome with citizen science.

While the sequencing of the human genome has provided invaluable knowledge, it is very difficult to change their own genetic makeup. The microbiome, in contrast, is much more easily changed through simple means such as healthful probiotic cultures and other lifestyle interventions. The microbiome thus may provide some of the most important medical breakthroughs of their era. uBiome will ultimately empower participants to manage their microbiomes to improve their health as well as make important scientific discoveries for humanity.


Funding History

July 2014$120K
August 2014$4.5M


Cofounder and CEO

Jessica Richman

Cofounder and CTO

Zachary Apte


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: